Skip to main content


Fig. 2 | Journal of Ovarian Research

Fig. 2

From: Olaparib in the therapy of advanced ovarian cancer: first real world experiences in safety and efficacy from China

Fig. 2

CA125 values in each group. Note: The CA125 level of the first follow-up was used as the reference value, and all data were converted to natural logarithm. CA125 follow-up data were obtained from 2 patient in the first-line maintenance treatment group, 10 patients in the second-line maintenance treatment group, 6 patients in the multi-line therapy group, and 10 patients in the exploratory therapy group

Back to article page